GSK, Other Pharma Cos. Seek Exclusion From New OECD Tax
By Alex M. Parker · November 15, 2019, 7:00 PM EST
GlaxoSmithKline, AstraZeneca, Johnson & Johnson and other pharmaceutical companies have lobbied the OECD to exclude the industry from its newly proposed consumer-based taxing system, arguing they don't directly sell products to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login
